Allworth Financial LP Cuts Stock Holdings in CVS Health Corporation $CVS

Key Points

• Allworth Financial cut its CVS Health stake by 65.5% in the second quarter, selling 63,048 shares and retaining 33,215 shares valued at approximately $3.4 million.
• Institutional ownership remains substantial at 80.66%, with major investors including California State Teachers Retirement System, BlackRock, State Street, Wellington Management and Capital International Investors increasing or initiating positions.
• CVS reported quarterly EPS of $2.58, beating the $1.87 consensus estimate, while revenue rose 7.3% year over year to $106.1 billion. The company reaffirmed fiscal 2026 EPS guidance of $7.90–$8.10 and pays a quarterly dividend of $0.665 per share.

Allworth Financial LP reduced its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 65.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,215 shares of the pharmacy operator's stock after selling 63,048 shares during the period. Allworth Financial LP's holdings in CVS Health were worth $3,436,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. California State Teachers Retirement System lifted its position in CVS Health by 10,133.9% during the second quarter. California State Teachers Retirement System now owns 193,320,429 shares of the pharmacy operator's stock valued at $19,998,998,000 after purchasing an additional 191,431,405 shares during the last quarter. BlackRock Inc. bought a new position in shares of CVS Health in the 2nd quarter valued at about $12,747,462,000. State Street Corp grew its position in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator's stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares in the last quarter. Wellington Management Group LLP increased its stake in CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator's stock worth $3,496,725,000 after acquiring an additional 11,233,381 shares during the last quarter. Finally, Capital International Investors increased its stake in CVS Health by 3.4% during the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator's stock worth $2,189,793,000 after acquiring an additional 900,153 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of CVS Health stock opened at $95.31 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock's fifty day moving average is $100.12 and its two-hundred day moving average is $90.74. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a market capitalization of $121.90 billion, a PE ratio of 25.21, a price-to-earnings-growth ratio of 0.93 and a beta of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period last year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health's dividend payout ratio (DPR) is currently 70.37%.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Updated 2026–2027 COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic locations nationwide. Most insured patients can receive them at no cost, with appointments available through CVS.com or the app and walk-ins accepted. The rollout could support pharmacy and clinic traffic, although its financial impact is likely modest. Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic
• Positive Sentiment: Analysts and financial commentators point to CVS’s pharmacy growth, specialty-pharmacy expansion, AI investments, GLP-1 opportunities and potential Aetna margin recovery as drivers of a turnaround. Recent quarterly results showed revenue of $106.1 billion, up 7.3% year over year, while adjusted operating income reportedly rose 35%. CVS Health: Buy the Pullback Before Earnings Power Ramps Up
• Positive Sentiment: CVS is being viewed as attractively valued, with commentary citing roughly 12-times forward earnings versus healthcare peers. Its latest reported adjusted EPS of $2.58 exceeded the $1.87 consensus estimate, and full-year 2026 guidance remains $7.90–$8.10 per share. Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?
• Neutral Sentiment: CVS’s 20-year community health-screening program and new survey emphasize unmet demand for preventive care. The initiative may strengthen the company’s community-health brand, but the announcement is primarily reputational rather than a near-term earnings catalyst. CVS Health Marks 20 Years of Free Community Health Screening
• Negative Sentiment: CVS flagged elevated medical expenses, renewing concerns about managed-care profitability and Aetna margins. Investors also continue to monitor reimbursement pressure and regulatory scrutiny, which could offset gains from pharmacy growth and leave the stock under pressure despite its discounted valuation. CVS Health Flags Elevated Medical Expenses

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Mizuho raised their price objective on CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a research note on Monday, June 8th. JPMorgan Chase & Co. boosted their target price on CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Wall Street Zen upgraded CVS Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 8th. Bank of America raised their price target on CVS Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, June 22nd. Finally, Truist Financial lifted their price objective on shares of CVS Health from $108.00 to $118.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Twenty-two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $107.24.

CVS Health Profile

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.